Phreesia and Allscripts partner to maximize profitability and operational efficiency in the healthcare industry

Published on:

NEW YORK, Aug. 12, 2014-- Phreesia, the leader in healthcare point of service, is the first certified partner to support integrations with Allscripts EHR and Allscripts PM products as part of the Allscripts Developer Program to offer clients enhanced functionality for Allscripts' clinical solutions. By integrating with both products, Phreesia's unrivaled interface with Allscripts offers users a single, unified platform from which they can streamline front-office workflow, increase cash flow and shift staff to higher-value tasks.

"The Phreesia integration with both Allscripts Professional EHR and Allscripts PM has helped us move from a good practice to a thriving practice," says Debra Jenkins, Business Services Director at Columbia Medical Practice in Columbia, Maryland. "We save countless hours of data entry, and by having patients check in with Phreesia, we're confident that our patient records are always complete and that we are optimizing our collections. The truly seamless integration between the two systems has become a necessity for maintaining efficiency and profitability."

Phreesia's innovative patient self-service platform, which includes electronic payment collection, data collection and consent form management, helps medical practices automate front-office workflow and drive tangible bottom-line results. Through its partnership with Allscripts, Phreesia brings EHR and PM users a tightly integrated solution that enables the seamless flow of information, while eliminating redundant data entry. Phreesia processes millions of healthcare transactions for Allscripts practices, and in the short amount of time the companies have been working together, Phreesia has eliminated more than 30 million pieces of paper, collected over $100 million in patient responsibility payments and saved more than $30 million in denied claims for Allscripts customers.

"We are proud to have developed a holistic solution for Allscripts users," says Phreesia CEO Chaim Indig. "Allscripts is a wonderful partner for us, and together, we are revolutionizing the healthcare industry by helping practices better manage patient flow, increase revenue and improve focus on patient care."

More about Phreesia's applications can be found at the Allscripts Application Store.

About Phreesia

Leading healthcare organizations choose Phreesia to revolutionize their point of service. Regardless of size, specialty or demographics, today's healthcare systems face the same challenges: escalating demands, rising costs and increasing patient responsibility. Phreesia's innovative point-of-service platform—including patient self-service and mobile applications—resolves these issues by driving efficiency and profitability throughout your organization. Your patients expect a seamless, automated experience from other industries. Why should your front office be any different?

Logo - http://photos.prnewswire.com/prnh/20140812/135545

SOURCE Phreesia, Inc.

CONTACT: Emily Nelson, Marketing Communications Director, Phreesia, enelson@phreesia.com, (212) 419-0130

RELATED LINKS
http://www.phreesia.com

Related Content

Christmas ransomware exposed over 300K patient records to dark web
Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.